Skip to search formSkip to main contentSkip to account menu

LE-SN38

Known as: Liposome entrapped 7-ethyl-10-hydroxycamptothecin, Liposome entrapped SN38, liposomal SN38 
The liposomal formulation of SN-38 (7-ethyl-10-hydroxy-camptothecin), a biologically active metabolite of the prodrug irinotecan, with potential… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
7-Ethyl-10-hydroxy camptothecin (SN38) is a potent topoisomerase inhibitor and a metabolite of irinotecan. Its clinical… 
2016
2016
Self-assembled nanoparticles (NPs) have been intensively utilized as cancer drug delivery carriers because hydrophobic anticancer… 
2015
2015
When gold nanoparticles (AuNPs) become extremely small (<2 nm in diameter) as gold nanoclusters (AuNCs), an intriguing issue is… 
2013
2013
Background: IMMU-130 is an ADC comprising the humanized monoclonal IgG antibody (mAb), hMN-14 (labetuzumab), bound to the active… 
2013
2013
SummaryThe present studies were carried out to examine the efficacy of a nanoparticulate formulation of SN38, the potent… 
2007
2007
The safety and efficacy of combination therapy with 7-ethyl-10-[4-[1-piperidino]-1-piperidino]carbonyloxycamptothecin (CPT-11… 
1995
1995
The inhibition of carbocyclic inosine (C-Ino), 3'-deoxyinosine (3'-dI), and 3'-fluoroinosine (3'-FI) to Leishmania donovani… 
1987
1987
SummaryIt is shown in the present study that RAW 264 tumor cells can be killed by liposomeentrapped dichloromethylene…